# Hoechst Marion Roussel · 66-66 · FRANCE — FDA import alert red lists: firms subject to detention without physical examination

For Hoechst Marion Roussel · 66-66 · FRANCE, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is FRANCE; product is L-Corbadrine HCl | Levonogeestrel | Fluorometholone | Clomiphene Citrate | Pentoxifylline; product code is 60 C - S 42 Levonordefrin (Adrenergic), Active Pharm Ingred/Chems for Further Manuf | 64 G - S 29 Levonorgestrel (Estrogen), Active Pharm Ingred/Chems for Further Manuf | 64 L - S 31 Fluorometholone (Glucocorticoid), Active Pharm Ingred/Chems for Further Manuf | 64 M - S 01 Clomiphene Citrate (Gonad-Stimulating Principle), Active Pharm Ingred/Chems for Further Manuf | 66 S - S 49 Pentoxifylline (Vasodilator), Active Pharm Ingred/Chems for Further Manuf; date published is 03/29/2019; address is Terrasse Bellini , Puteaux, FRANCE, verified against its source on 2026-09-16.

- **Firm:** Hoechst Marion Roussel _(verified: appears in the quote below)_
- **Import alert:** 66-66
- **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- **Country:** FRANCE _(verified: appears in the quote below)_
- **Address:** Terrasse Bellini , Puteaux, FRANCE _(verified: appears in the quote below)_
- **Date published:** 03/29/2019 _(verified: appears in the quote below)_
- **Product code:** 60 C - S 42 Levonordefrin (Adrenergic), Active Pharm Ingred/Chems for Further Manuf | 64 G - S 29 Levonorgestrel (Estrogen), Active Pharm Ingred/Chems for Further Manuf | 64 L - S 31 Fluorometholone (Glucocorticoid), Active Pharm Ingred/Chems for Further Manuf | 64 M - S 01 Clomiphene Citrate (Gonad-Stimulating Principle), Active Pharm Ingred/Chems for Further Manuf | 66 S - S 49 Pentoxifylline (Vasodilator), Active Pharm Ingred/Chems for Further Manuf _(verified: each item appears in the quote below)_
- **Product:** L-Corbadrine HCl | Levonogeestrel | Fluorometholone | Clomiphene Citrate | Pentoxifylline _(verified: each item appears in the quote below)_
- **FDA notes:** 11/2/2000 | 11/2/2000 | 11/2/2000 | 11/2/2000 | 11/2/2000 _(verified: each item appears in the quote below)_

## What the source says

> Hoechst Marion Roussel Date Published : 03/29/2019 Terrasse Bellini , Puteaux, FRANCE 60 C - S 42 Levonordefrin (Adrenergic), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: L-Corbadrine HCl Notes: 11/2/2000 64 G - S 29 Levonorgestrel (Estrogen), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Levonogeestrel Notes: 11/2/2000 64 L - S 31 Fluorometholone (Glucocorticoid), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Fluorometholone Notes: 11/2/2000 64 M - S 01 Clomiphene Citrate (Gonad-Stimulating Principle), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Clomiphene Citrate Notes: 11/2/2000 66 S - S 49 Pentoxifylline (Vasodilator), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Pentoxifylline Notes: 11/2/2000

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).